A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
China
Fudan University ShangHai Cancer Center, Shanghai, Shanghai Municipality Age range
18 Years – 75 Years
Last updated September 2025